Institutional Ownership Bio Line Rx Ltd. (BLRX)
This table provides information about the institutional ownership of Bio Line Rx Ltd. (BLRX). We have compiled data on the 36 institutions that hold shares in the stock, with a total of 2.83 Million shares, which have been reported (via 13F filing form) to have a value of $9.03 Million.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Highbridge Capital Management LLC
New York, NY |
Feb 12, 2025 Q4 2024 |
1,010,012
shares
|
$3.22 Million
0.05% of portfolio
|
Q4 2024
New holding
|
|
Cvi Holdings, LLC
Wilmington, DE |
Aug 15, 2024 Q2 2024 |
815,683
shares
|
$2.6 Million
4.05% of portfolio
|
Q2 2024
New holding
|
|
Values First Advisors, Inc.
|
Jan 29, 2025 Q4 2024 |
166,449
shares
|
$530,972
0.02% of portfolio
|
Q4 2024
Reduced 15.73%
|
|
Atria Wealth Solutions, Inc.
New York, NY |
Jan 31, 2025 Q4 2024 |
94,133
shares
|
$300,284
0.0% of portfolio
|
Q3 2024
Reduced 5.23%
|
|
Lpl Financial LLC
Fort Mill, SC |
Feb 11, 2025 Q4 2024 |
92,000
shares
|
$293,480
0.0% of portfolio
|
Q3 2024
Added 12.2%
|
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
Feb 14, 2025 Q4 2024 |
87,215
shares
|
$278,215
0.0% of portfolio
|
Q4 2024
Added 383.67%
|
|
Morgan Stanley
New York, NY |
Feb 14, 2025 Q4 2024 |
79,102
shares
|
$252,335
0.0% of portfolio
|
Q4 2024
Reduced 59.96%
|
|
Orin Green Financial, LLC
|
Feb 19, 2025 Q4 2024 |
51,000
shares
|
$162,690
0.0% of portfolio
|
Q4 2024
Added 18.6%
|
|
Rhumbline Advisers
Boston, MA |
Jan 30, 2025 Q4 2024 |
42,961
shares
|
$137,045
0.0% of portfolio
|
Q4 2024
Added 31.74%
|
|
Gradient Investments LLC
|
Jan 21, 2025 Q4 2024 |
41,400
shares
|
$132,066
0.0% of portfolio
|
Q4 2024
Added 38.0%
|
|
Geode Capital Management, LLC
Boston, MA |
Feb 12, 2025 Q4 2024 |
39,993
shares
|
$127,577
0.0% of portfolio
|
Q4 2023
Added 24.88%
|
|
Two Sigma Securities, LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
35,310
shares
|
$112,638
0.0% of portfolio
|
Q4 2024
New holding
|
|
Watts Gwilliam & Co., LLC
Gilbert, AZ |
Jan 08, 2025 Q4 2024 |
34,000
shares
|
$108,460
0.0% of portfolio
|
Q4 2024
New holding
|
|
Rathbones Group PLC
Liverpool, X0 |
Feb 13, 2025 Q4 2024 |
31,666
shares
|
$101,014
0.0% of portfolio
|
Q4 2024
Reduced 20.48%
|
|
Citigroup Inc
|
Feb 12, 2025 Q4 2024 |
31,337
shares
|
$99,965
0.0% of portfolio
|
Q4 2024
New holding
|
|
Act Capital Management, LLC
Wayne, PA |
Nov 03, 2022 Q3 2022 |
27,500
shares
|
$87,725
0.03% of portfolio
|
Q2 2021
New holding
|
|
Royal Bank Of Canada
Toronto, A6 |
Feb 14, 2025 Q4 2024 |
20,200
shares
|
$64,438
0.0% of portfolio
|
Q4 2024
New holding
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Feb 14, 2025 Q4 2024 |
15,314
shares
|
$48,851
0.0% of portfolio
|
Q4 2024
New holding
|
|
Creative Planning
Overland Park, KS |
Feb 14, 2025 Q4 2024 |
12,982
shares
|
$41,412
0.0% of portfolio
|
Q3 2024
Reduced 0.76%
|
|
Nemes Rush Group LLC
Novi, MI |
Feb 12, 2025 Q4 2024 |
12,000
shares
|
$38,280
0.0% of portfolio
|
Q2 2023
New holding
|
|
Qube Research & Technologies LTD
London, X0 |
Feb 14, 2025 Q4 2024 |
11,935
shares
|
$38,072
0.0% of portfolio
|
Q4 2024
Reduced 8.44%
|
|
Weaver Consulting Group
|
Jan 07, 2025 Q4 2024 |
11,000
shares
|
$35,090
0.0% of portfolio
|
Q4 2024
Reduced 63.02%
|
|
Wealth Enhancement Advisory Services, LLC
|
Mar 17, 2025 Q4 2024 |
10,500
shares
|
$33,495
0.0% of portfolio
|
Q3 2024
New holding
|
|
Hibernia Wealth Partners, LLC
Baton Rouge, LA |
Jan 29, 2025 Q4 2024 |
10,000
shares
|
$31,900
0.0% of portfolio
|
Q4 2024
New holding
|
|
Neville Rodie & Shaw Inc
|
Jan 06, 2025 Q4 2024 |
10,000
shares
|
$31,900
0.0% of portfolio
|
Q4 2024
New holding
|